News
See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!
SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.
Theratechnologies entered a definitive agreement to be acquired by Future Pak. Find out why do not expect to see THTX stock ...
The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...
GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results